<DOC>
	<DOCNO>NCT02302391</DOCNO>
	<brief_summary>Pharmacokinetic monitoring midazolam , 's active metabolite fentanyl pediatric patient long-term analgosedation perform . Especially , chronologic sequence quantify plasma level sedation wake-up well correlation dose sedation depth focus .</brief_summary>
	<brief_title>Pharmacokinetic Analysis Midazolam Fentanyl Pediatric Patients With Long-term Analgosedation</brief_title>
	<detailed_description>At pre-defined timepoints ( see ) serum Levels mention drug metabolite determine pharmakokinetic ( PK ) modeling perform . PK data correlate sedation depth , assess use validate score . Three Age Groups ( infant , child adolescent ) evaluate consider physiologic property pediatric development .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>pediatric patient 28 day 17 year age mechanical ventilation 3 day analgosedation midazolam fentanyl miss inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>